Business Context and Reporting Period
This Form 8-K was filed on September 13, 2021 by Eliem Therapeutics, Inc. for the quarter ended June 30, 2021. The filing reports that the company issued a press release announcing quarterly financial results. The request metadata identifies the company as Climb Bio, Inc., but the filing itself identifies the registrant as Eliem Therapeutics, Inc.
The company was incorporated in Delaware and its common stock traded on Nasdaq under the symbol ELYM. The filing identifies the company as an emerging growth company.
Financial Results and Key Metrics
The filing references financial results for the quarter ended June 30, 2021, but the supplied text does not include the attached Exhibit 99.1 press release or specific financial data.
- Revenue: The filing text does not provide a clear value.
- Net income or loss: The filing text does not provide a clear value.
- Cash flow: The filing text does not provide a clear value.
- Margins: The filing text does not provide a clear value.
- Debt and liquidity: The filing text does not provide a clear value.
Material Changes Versus Prior Period
The filing does not provide sufficient financial information to assess changes versus the prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, risk updates, contingencies, or unusual items are included in the supplied filing text. These matters may have been discussed in the referenced but unavailable press release.
The financial-results disclosure was furnished under Item 2.02 and was expressly stated not to be deemed filed for purposes of Section 18 of the Exchange Act or incorporated by reference into other filings.
Facts Investors Should Verify
- Obtain and review Exhibit 99.1 for the actual quarterly financial results, cash balance, operating expenses, net loss, and cash runway.
- Confirm the registrant’s corporate identity, because the filing names Eliem Therapeutics, Inc., while the request metadata names Climb Bio, Inc.
- Review any guidance, pipeline updates, financing activity, or risk disclosures contained in the referenced press release.
- Compare the June 30, 2021 results with the prior-year and immediately preceding quarter once the missing financial statements or press release are available.